| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
|
Mahoney, Kathleen M.
|
|
2018
|
68 |
3 |
p. 421-432
|
artikel
|
| 2 |
CD73 expression in normal and pathological human hepatobiliopancreatic tissues
|
Sciarra, Amedeo
|
|
2019
|
68 |
3 |
p. 467-478
|
artikel
|
| 3 |
Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance
|
Malyshkina, Anna
|
|
2019
|
68 |
3 |
p. 479-488
|
artikel
|
| 4 |
Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues
|
Sciarra, Amedeo
|
|
2019
|
68 |
3 |
p. 529
|
artikel
|
| 5 |
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
|
Hu, Wanghong
|
|
2018
|
68 |
3 |
p. 365-377
|
artikel
|
| 6 |
Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater
|
Kim, Min Hwan
|
|
2019
|
68 |
3 |
p. 443-454
|
artikel
|
| 7 |
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
|
Llopiz, Diana
|
|
2018
|
68 |
3 |
p. 379-393
|
artikel
|
| 8 |
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
|
Llopiz, Diana
|
|
|
68 |
3 |
p. 379-393
|
artikel
|
| 9 |
Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8+ T cells from negative regulation by local IFN-γ
|
Lin, Lin
|
|
2018
|
68 |
3 |
p. 395-405
|
artikel
|
| 10 |
Identification and characterization of an alternative cancer-derived PD-L1 splice variant
|
Hassounah, Nadia B.
|
|
2018
|
68 |
3 |
p. 407-420
|
artikel
|
| 11 |
Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
|
Zhou, Rui
|
|
2018
|
68 |
3 |
p. 433-442
|
artikel
|
| 12 |
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
|
Nadal, Ernest
|
|
2019
|
68 |
3 |
p. 341-352
|
artikel
|
| 13 |
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
|
Chiappori, Alberto A.
|
|
2018
|
68 |
3 |
p. 517-527
|
artikel
|
| 14 |
STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes
|
Andersen, Morten Nørgaard
|
|
2019
|
68 |
3 |
p. 489-502
|
artikel
|
| 15 |
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma
|
Chang, Boyang
|
|
2018
|
68 |
3 |
p. 353-363
|
artikel
|
| 16 |
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial
|
Huijts, Charlotte M.
|
|
2019
|
68 |
3 |
p. 503-515
|
artikel
|
| 17 |
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
|
Sultan, Hussein
|
|
2019
|
68 |
3 |
p. 455-466
|
artikel
|
Tijdschrift beschrijving